AAAAAA
Results:
1-22
|
Results: 22
Authors:
BALLY MB
LIM H
CULLIS PR
MAYER LD
Citation: Mb. Bally et al., CONTROLLING THE DRUG-DELIVERY ATTRIBUTES OF LIPID-BASED DRUG FORMULATIONS, Journal of liposome research, 8(3), 1998, pp. 299-335
Authors:
WEBB MS
LOGAN P
KANTER PM
STONGE G
GELMON K
HARASYM T
MAYER LD
BALLY MB
Citation: Ms. Webb et al., PRECLINICAL PHARMACOLOGY, TOXICOLOGY AND EFFICACY OF SPHINGOMYELIN CHOLESTEROL LIPOSOMAL VINCRISTINE FOR THERAPEUTIC TREATMENT OF CANCER/, Cancer chemotherapy and pharmacology, 42(6), 1998, pp. 461-470
Authors:
EMBREE L
GELMON K
TOLCHER A
HUDON N
HEGGIE J
DEDHAR C
LOGAN P
BALLY MB
MAYER LD
Citation: L. Embree et al., PHARMACOKINETIC BEHAVIOR OF VINCRISTINE SULFATE FOLLOWING ADMINISTRATION OF VINCRISTINE SULFATE LIPOSOME INJECTION, Cancer chemotherapy and pharmacology, 41(5), 1998, pp. 347-352
Authors:
MAYER LD
Citation: Ld. Mayer, FUTURE-DEVELOPMENTS IN THE SELECTIVITY OF ANTICANCER AGENTS - DRUG-DELIVERY AND MOLECULAR TARGET STRATEGIES, Cancer metastasis reviews, 17(2), 1998, pp. 211-218
Authors:
WEBB MS
SAXON D
WONG FMP
LIM HJ
WANG Z
BALLY MB
CHOI LSL
CULLIS PR
MAYER LD
Citation: Ms. Webb et al., COMPARISON OF DIFFERENT HYDROPHOBIC ANCHORS CONJUGATED TO POLY(ETHYLENE GLYCOL) - EFFECTS ON THE PHARMACOKINETICS OF LIPOSOMAL VINCRISTINE, Biochimica et biophysica acta. Biomembranes, 1372(2), 1998, pp. 272-282
Authors:
EMBREE L
GELMON KA
TOLCHER AW
HUDON NJ
HEGGIE JR
DEDHAR C
WEBB MS
BALLY MB
MAYER LD
Citation: L. Embree et al., VALIDATION OF A HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY-METHOD FOR QUANTIFICATION OF TOTAL VINCRISTINE SULFATE IN HUMAN PLASMA FOLLOWING ADMINISTRATION OF VINCRISTINE SULFATE LIPOSOME INJECTION, Journal of pharmaceutical and biomedical analysis, 16(4), 1997, pp. 675-687
Authors:
CULLIS PR
HOPE MJ
BALLY MB
MADDEN TD
MAYER LD
FENSKE DB
Citation: Pr. Cullis et al., INFLUENCE OF PH GRADIENTS ON THE TRANSBILAYER TRANSPORT OF DRUGS, LIPIDS, PEPTIDES AND METAL-IONS INTO LARGE UNILAMELLAR VESICLES, Biochimica et biophysica acta, MR. Reviews on biomembranes, 1331(2), 1997, pp. 187-211
Authors:
KRISHNA R
DEJONG G
MAYER LD
Citation: R. Krishna et al., PULSED EXPOSURE OF SDZ PSC-833 TO MULTIDRUG-RESISTANT P388 ADR AND MCF7/ADR CELLS IN THE ABSENCE OF ANTICANCER DRUGS CAN FULLY RESTORE SENSITIVITY TO DOXORUBICIN/, Anticancer research, 17(5A), 1997, pp. 3329-3334
Authors:
MAYER LD
DOUGHERTY G
HARASYM TO
BALLY MB
Citation: Ld. Mayer et al., THE ROLE OF TUMOR-ASSOCIATED MACROPHAGES IN THE DELIVERY OF LIPOSOMALDOXORUBICIN TO SOLID MURINE FIBROSARCOMA TUMORS, The Journal of pharmacology and experimental therapeutics, 280(3), 1997, pp. 1406-1414
Authors:
KRISHNA R
MAYER LD
Citation: R. Krishna et Ld. Mayer, LIPOSOMAL DOXORUBICIN CIRCUMVENTS PSC 833-FREE DRUG-INTERACTIONS, RESULTING IN EFFECTIVE THERAPY OF MULTIDRUG-RESISTANT SOLID TUMORS, Cancer research, 57(23), 1997, pp. 5246-5253
Authors:
KANTER PM
KING JM
BALLY MB
MAYER LD
Citation: Pm. Kanter et al., LIPOSOME-ENCAPSULATED VINCRISTINE - PRECLINICAL TOXICOLOGIC AND PHARMACOLOGICAL COMPARISON WITH FREE VINCRISTINE AND EMPTY LIPOSOMES IN MICE, RATS AND DOGS - REPLY, Anti-cancer drugs, 6(2), 1995, pp. 329-330
Authors:
WEBB MS
HARASYM TO
MASIN D
BALLY MB
MAYER LD
Citation: Ms. Webb et al., SPHINGOMYELIN-CHOLESTEROL LIPOSOMES SIGNIFICANTLY ENHANCE THE PHARMACOKINETIC AND THERAPEUTIC PROPERTIES OF VINCRISTINE IN MURINE AND HUMANTUMOR-MODELS, British Journal of Cancer, 72(4), 1995, pp. 896-904
Authors:
MAYER LD
MASIN D
NAYAR R
BOMAN NL
BALLY MB
Citation: Ld. Mayer et al., PHARMACOLOGY OF LIPOSOMAL VINCRISTINE IN MICE BEARING L1210 ASCITIC AND B16 BL6 SOLID TUMORS/, British Journal of Cancer, 71(3), 1995, pp. 482-488
Authors:
WEBB MS
WHEELER JJ
BALLY MB
MAYER LD
Citation: Ms. Webb et al., THE CATIONIC LIPID STEARYLAMINE REDUCES THE PERMEABILITY OF THE CATIONIC DRUGS VERAPAMIL AND PROCHLORPERAZINE TO LIPID BILAYERS - IMPLICATIONS FOR DRUG-DELIVERY, Biochimica et biophysica acta. Biomembranes, 1238(2), 1995, pp. 147-155
Authors:
MAYER LD
STONGE G
Citation: Ld. Mayer et G. Stonge, DETERMINATION OF FREE AND LIPOSOME-ASSOCIATED DOXORUBICIN AND VINCRISTINE LEVELS IN PLASMA UNDER EQUILIBRIUM CONDITIONS EMPLOYING ULTRAFILTRATION TECHNIQUES, Analytical biochemistry, 232(2), 1995, pp. 149-157
Authors:
KANTER PM
KLAICH GM
BULLARD GA
KING JM
BALLY MB
MAYER LD
Citation: Pm. Kanter et al., LIPOSOME-ENCAPSULATED VINCRISTINE - PRECLINICAL TOXICOLOGIC AND PHARMACOLOGICAL COMPARISON WITH FREE VINCRISTINE AND EMPTY LIPOSOMES IN MICE, RATS AND DOGS, Anti-cancer drugs, 5(5), 1994, pp. 579-590
Authors:
BALLY MB
MASIN D
NAYAR R
CULLIS PR
MAYER LD
Citation: Mb. Bally et al., TRANSFER OF LIPOSOMAL DRUG CARRIERS FROM THE BLOOD TO THE PERITONEAL-CAVITY OF NORMAL AND ASCITIC TUMOR-BEARING MICE, Cancer chemotherapy and pharmacology, 34(2), 1994, pp. 137-146
Authors:
NATARAJ HC
COOPER A
ZHOU KR
MAYER LD
KANG BC
Citation: Hc. Nataraj et al., ATOPIC PROFILE OF LEXINGTON ALLERGY CLINIC POPULATION (LAC), Journal of allergy and clinical immunology, 93(1), 1994, pp. 191-191
Authors:
BOMAN NL
MASIN D
MAYER LD
CULLIS PR
BALLY MB
Citation: Nl. Boman et al., LIPOSOMAL VINCRISTINE WHICH EXHIBITS INCREASED DRUG RETENTION AND INCREASED CIRCULATION LONGEVITY CURES MICE BEARING P388 TUMORS, Cancer research, 54(11), 1994, pp. 2830-2833
Authors:
MAYER LD
NAYAR R
THIES RL
BOMAN NL
CULLIS PR
BALLY MB
Citation: Ld. Mayer et al., IDENTIFICATION OF VESICLE PROPERTIES THAT ENHANCE THE ANTITUMOR-ACTIVITY OF LIPOSOMAL VINCRISTINE AGAINST MURINE L1210 LEUKEMIA, Cancer chemotherapy and pharmacology, 33(1), 1993, pp. 17-24
Authors:
EMBREE L
GELMON KA
LOHR A
MAYER LD
COLDMAN AJ
CULLIS PR
PALAITIS W
PILKIEWICZ F
HUDON NJ
HEGGIE JR
GOLDIE JH
Citation: L. Embree et al., CHROMATOGRAPHIC ANALYSIS AND PHARMACOKINETICS OF LIPOSOME-ENCAPSULATED DOXORUBICIN IN NON-SMALL-CELL LUNG-CANCER PATIENTS, Journal of pharmaceutical sciences, 82(6), 1993, pp. 627-634
Authors:
BOMAN NL
MAYER LD
CULLIS PR
Citation: Nl. Boman et al., OPTIMIZATION OF THE RETENTION PROPERTIES OF VINCRISTINE IN LIPOSOMAL SYSTEMS, Biochimica et biophysica acta, 1152(2), 1993, pp. 253-258
Risultati:
1-22
|